Role of Danggui Buxue Decoction for the prevention and treatment of cardiovascular and pulmonary diseases.

Journal: Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences

Volume: 48

Issue: 10

Year of Publication: 2024

Affiliated Institutions:  Department of Pharmacy, th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army, Lanzhou . jianglinzlj@.com. Department of Pharmacy, th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army, Lanzhou . Department of Pharmacy, th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army, Lanzhou . wangrong-@.com.

Abstract summary 

Cardiovascular and pulmonary diseases have become the major disease endangering people's physical and mental health because of its high morbidity and mortality. Danggui Buxue Decoction, a noteworthy classical prescription, is composed of astragali radix and angelicae sinensis radix at a ratio of 5꞉1. It is a prescription for tonifying both vital energy and blood and has the effect of dredging collaterals. Its main active components, such as polysaccharides, saponins, flavonoids and volatile oils, have good effects on antioxidation, inflammation regulation, immune regulation and promotion of blood circulation. Danggui Buxue Decoction can improve myocardial ischemia-reperfusion injury and heart failure, relieve the symptoms of diabetic cardiomyopathy, inhibit pulmonary fibrosis, protect lung injury and fight against lung cancer and other cardiopulmonary diseases. Preclinical studies have showed that this prescription can inhibit inflammation and oxidative stress, regulate autophagy and enhance immune function through multi-target pathways. Reviewing the main effective components, pharmacological action and mechanism, and clinical application of Danggui Buxue Decoction are helpful to provide comprehensive information for the clinical application of Danggui Buxue Decoction in prevention and treatment of cardiovascular and pulmonary diseases.

Authors & Co-authors:  Jiang Chen Li Wang

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Joseph P, Leong D, McKee M, et al. . Reducing the global burden of cardiovascular disease, part 1: The epidemiology and risk factors[J]. Circ Res, 2017, 121(6): 677-694. 10.1161/CIRCRESAHA.117.308903.
Authors :  4
Identifiers
Doi : 10.11817/j.issn.1672-7347.2023.230198
SSN : 1672-7347
Study Population
Male,Female
Mesh Terms
Humans
Other Terms
Danggui Buxue Decoction;active ingredients;cardiovascular and pulmonary diseases;clinical application;pharmacological effect
Study Design
Study Approach
Country of Study
Publication Country
China